Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-04

Clinical Trial Update: Tranexamic Acid During Cystectomy Trial (TACT) [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 trial evaluating tranexamic acid during cystectomy for bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Bladder Cancer | Phase 2, Phase 3 | Status: COMPLETED